DGCR8 is essential for tumor progression following PTEN loss in the prostate

Cassandra D. Belair, Alireza Paikari, Felix Moltzahn, Archana Shenoy, Christina Yau, Marc Dall'Era, Jeff Simko, Christopher Benz, Robert Blelloch

Research output: Contribution to journalArticlepeer-review

11 Scopus citations

Fingerprint

Dive into the research topics of 'DGCR8 is essential for tumor progression following PTEN loss in the prostate'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds